Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

193.43
Delayed Data
As of Dec 11
 +2.07 / +1.08%
Today’s Change
103.53
Today|||52-Week Range
200.28
+71.66%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close191.36
Today’s open191.36
Day’s range191.08 - 193.84
Volume258,837
Average volume (3 months)332,701
Market cap$8.5B
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+99.57%
Earnings growth (next 5 years)+41.50%
Revenue growth (last year)+35.13%
P/E ratio94.8
Price/Sales12.56
Price/Book18.49

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc-3.08-5.01%
WSTWest Pharmaceutical ...-0.55-0.55%
MASIMasimo Corp-0.50-0.58%
IARTIntegra LifeSciences...-0.09-0.18%
Data as of 4:02pm ET, 12/11/2017

Financials

Next reporting dateFebruary 1, 2018
EPS forecast (this quarter)$0.50
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts